Bozic Carmen 4

What Happened
Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), surrendered 1,453 shares on Feb 24, 2026 to satisfy tax withholding associated with an equity event. The shares were valued at $485.11 each, for a total value of approximately $704,865. This was a tax-withholding/settlement action (code F), not an open-market sale.

Key Details

• Transaction date: 2026-02-24; filing date: 2026-02-26 (timely file).
• Shares surrendered/withheld: 1,453 at $485.11 per share; total value ≈ $704,865.
• Transaction code: F — payment of exercise price or tax liability (shares withheld to cover taxes).
• Shares owned after the transaction: not reported in the provided filing excerpt.
• Filing timeliness: filed within two days of the transaction; no late-filing flag indicated.

Context
A Code F transaction typically reflects withholding of shares to satisfy tax obligations after an option exercise or vesting of restricted stock. Because the shares were surrendered for taxes rather than sold on the open market, this transaction is generally administrative and not a direct signal of buying or selling sentiment.